General Information of the Compound
| Compound ID |
CP0440530
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
US8722896, (-)-(3R)-1-(3-Methoxybenzyl)- N-(9-chloro-3,4-dihydro-2H-1,5- benzodioxepin-7-ylmethyl)-N- isobutylpiperidine-3- carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C28H37ClN2O4
|
||||||||||||||||||
| Molecular Weight |
501.067
|
||||||||||||||||||
| Canonical SMILES |
COc1cccc(CN2CCCC(C2)C(=O)N(CC(C)C)Cc2cc(Cl)c3OCCCOc3c2)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C28H37ClN2O4/c1-20(2)16-31(18-22-14-25(29)27-26(15-22)34-11-6-12-35-27)28(32)23-8-5-10-30(19-23)17-21-7-4-9-24(13-21)33-3/h4,7,9,13-15,20,23H,5-6,8,10-12,16-19H2,1-3H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
COPODLXHIVJYHK-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00629, Prokineticin receptor 1
Protein ID: PT00615, Prokineticin receptor 2